LATTICE SEMICONDUCTOR CORP

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note1 - Basis of Presentation

Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses.

Basis of Presentation and Use of Estimates

The accompanying Consolidated Financial Statements are unaudited and have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In our opinion, they include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These Consolidated Financial Statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form10-K for the year ended* December 28, 2024 ("*2024 10-K").

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience* may*differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.

We describe our accounting methods and practices in more detail in our2024 10-K. There have beenno changes to the significant accounting policies, procedures, or general information described in our2024 10-K that have had a material impact on our consolidated condensed financial statements and the accompanying notes. Certain prior year balances have been reclassified to conform to the current year’s presentation.

Fiscal Reporting Periods

We report based on a52 or53-week fiscal year ending on the Saturday closest to* December 31.Our fiscal2025* will be a53-week year and will end on* January 3, 2026,and our fiscal2024* was a52-week year that ended* December 28, 2024.Oursecond* quarter of fiscal2025 andsecond quarter of fiscal2024 ended on* June 28, 2025and June 29, 2024*, respectively. All references to quarterly or year-to-date financial results are references to the results for the relevant13-week or26-week fiscal period.

Concentrations of Risk

Potential exposure to concentrations of risk* mayimpact revenue and trade accounts receivable. Sales to distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 84% and 91% for thesecond* quarters of fiscal2025 and2024, respectively and 81% and 89% for thefirst six months of fiscal2025 and2024, respectively. Distributors also account for a substantial portion of our net accounts receivable. At* June 28, 2025*, ourtwo largest distributors accounted for 51% and 32% of net accounts receivable, and at* December 28, 2024*, ourtwo largest distributors accounted for 45% and 36% of net accounts receivable.

New Accounting Pronouncements

In* December 2023,the FASB issued ASU2023*-09, Income Taxes (Topic740*) Improvements to Income Tax Disclosures*, which require greater disaggregation of income tax disclosures. ASU2023-09 aims to improve an entity’s income tax disclosures around its effective rate reconciliation, income taxes paid by jurisdiction, disaggregation of income before income taxes and income tax expense. This ASU should be applied on a prospective basis, but retrospective application is permitted. The guidance in this update is effective for fiscal years beginning after* December 15, 2024.We are currently evaluating the future effect of the adoption of this ASU will have on our consolidated financial statements and related disclosures, and donot* expect it will have a material impact on our consolidated results.

-10 -

In* November 2024,the FASB issued ASU2024*-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic220*-40): Disaggregation of Income Statement Expenses*. This new guidance requires public entities to provide disaggregated disclosures, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of income statement. The ASU* maybe applied prospectively or retrospectively and is effective for fiscal years beginning after December 15, 2026and for interim periods beginning after December 15, 2027.*Early adoption is permitted. We are currently evaluating the impact of adoption of this new guidance on our consolidated financial statements disclosures.

Note2 - Net Income per Share

We compute basic earnings per share based on the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period, if applicable. Potentially dilutive shares of common stock from employee equity incentive awards are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding restricted stock units ("RSUs") and restricted stock awards ("RSAs"), and the assumed issuance of common stock under the stock purchase plan.

Our calculation of potentially dilutive shares includes the number of shares from our equity awards with market conditions or performance conditions that would be issuable under the terms of such awards at the end of the reporting period. For equity awards with a market condition, the number of shares included in the diluted share count as of the end of each period presented is determined by measuring the achievement of the market condition as of the end of the respective reporting periods. For equity awards with a performance condition, the number of shares that qualified for vesting as of the end of each period presented are included in the diluted share count when the condition for their issuance was satisfied by the end of the respective reporting periods. See"Note9 - Stock-Based Compensation" to our consolidated financial statements for further discussion of our equity awards with market conditions or performance conditions.

A summary of basic and diluted Net income per share is presented in the following table:

The computation of diluted Net income per share excludes the effects of employee equity incentive awards that are antidilutive, aggregating approximately 1.8 million and 1.0 million shares for thesecond quarters of fiscal2025 and2024, respectively, and approximately 1.3 million and 0.9 million shares for thefirst six months of fiscal2025 and2024, respectively.

-11 -

Note3 - Revenue from Contracts with Customers

Disaggregation of Revenue

The following tables provide information about revenue from contracts with customers disaggregated by channel and by geographical market, based on ship-to location of our customers:

Contract Balances

Our contract assets relate primarily to our rights to consideration for licenses and royalties due to us as a member of the HDMI Founders consortium. The balance results primarily from the amount of estimated revenue related to HDMI that we have recognized to date, but which hasnot yet been distributed to us by the HDMI licensing agent. Contract assets are included in Prepaid expenses and other current assets on our Consolidated Balance Sheets. The following table summarizes activity during thefirst**six months of fiscal2025:

Contract liabilities are included in Accrued liabilities on our Consolidated Balance Sheets. The following table summarizes activity during thefirst**six months of fiscal2025:

-12 -

Note4 - Balance Sheet Components

Accounts Receivable

Accounts receivable donot bear interest and are shown net of an allowance for expected lifetime credit losses, which reflects our best estimate of probable losses inherent in the accounts receivable balance, as described in our2024 10-K.

Inventories

Property and Equipment – Geographic Information

Our Property and equipment, net by country at the end of each period was as follows:

Accrued Liabilities

Included in Accrued liabilities in the Consolidated Balance Sheets are the following balances:

Other Long-Term Liabilities

Included in Other long-term liabilities in the Consolidated Balance Sheets are the following balances:

-13 -

Note5 - Long-Term Debt

On* September 1, 2022,we entered into an Amended and Restated Credit Agreement (the“2022* Credit Agreement”), which provides for afive-year secured revolving loan facility with an aggregate principal amount of up to $350 million.

The revolving loans under the2022 Credit Agreement* maybe repaid and reborrowed at our discretion, with any remaining outstanding principal amount due and payable on the maturity date of the revolving loan on September 1, 2027.At June 28, 2025* and* December 28, 2024*, we hadno borrowings outstanding under the2022 Credit Agreement. We pay a quarterly commitment fee of 0.20% on the unused portion of the revolving facility.

Note6 - Restructuring

Under theQ3 2024 Plan, which is described in our2024 10-K, we incurred restructuring costs of approximately $1.5 million and $1.6 million in thesecond quarter andfirst six months, respectively, of fiscal2025. Under this plan, approximately $9.2 million of total costs have been incurred through* June 28, 2025.TheQ3* 2024 plan is expected to be largely complete by the end of fiscal year2025.

Under theQ3 2023 Plan, which is described in our2024 10-K, we incurredno restructuring costs during thefirst six months of fiscal2025, and restructuring costs of approximately $2.7 million and $5.0 million during thesecond quarter andfirst six months, respectively, of fiscal2024. Under this plan, approximately $7.3 million of total costs have been incurred through* June 28, 2025.All actions planned under theQ3* 2023 plan have been implemented.

Other restructuring activity in the periods presented consisted of expense adjustments on previous plans. Costs and adjustments on restructuring plans are recorded to Restructuring and other on our Consolidated Statements of Operations. The restructuring accrual balance is presented in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets. The following table displays the activity related to our restructuring plans:

Note7 - Leases

We have operating leases for corporate offices, sales offices, research and development facilities, storage facilities, and a data center. All of our facilities are leased under operating leases, which expire at various times through2035, with a weighted-average remaining lease term of 5.4 years and a weighted-average discount rate of 5.6% as of* June 28, 2025*.

We recorded fixed operating lease expenses of $2.3 million and $2.2 million for thesecond quarter of fiscal2025 and2024, respectively, and $4.4 million and $4.3 million for thefirst six months of fiscal2025 and2024, respectively.

The following table presents the lease balance classifications within the Consolidated Balance Sheets and summarizes their activity during thefirst six months of fiscal2025:

-14 -

Maturities of operating lease liabilities as of* June 28, 2025* are as follows:

Lease obligations for facilities restructured prior to the adoption of Topic842 totaled approximately$2.1 million at* June 28, 2025* and is recorded in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets.

Note8 - Intangible Assets

In connection with our past acquisitions and purchases of certain intellectual property assets, we have recorded identifiable intangible assets. We also enter into license agreements forthird-party technology and record them as intangible assets. These licenses are being amortized to Research and development expense over their estimated useful lives. On our Consolidated Balance Sheets at* June 28, 2025* and* December 28, 2024*, Intangible assets, net are shown net of accumulated amortization of $164.6 million and $163.5 million, respectively.

We recorded amortization expense related to intangible assets on the Consolidated Statements of Operations as presented in the following table: